What Are GLP-1 Medications?
GLP-1 medications are a class of drugs that mimic a natural hormone in your body called GLP-1 (glucagon-like peptide-1). This hormone is released by your gut after eating and plays a key role in regulating appetite, blood sugar, and digestion.
When you take a GLP-1 medication, you're essentially amplifying this natural signal — telling your brain you're full, slowing down digestion, and helping your body manage blood sugar more effectively. The result is reduced appetite, smaller portions, and for many people, significant weight loss.
These medications were originally developed for type 2 diabetes but have become transformative for weight management. They represent the most effective pharmaceutical approach to obesity treatment currently available.
How GLP-1 Medications Work
GLP-1 medications work through multiple pathways simultaneously:
In the Brain
- Appetite reduction: Acts on appetite centers in the hypothalamus to reduce hunger signals
- Reduced "food noise": Many patients report a dramatic decrease in constant thoughts about food
- Changed food preferences: Some patients develop decreased interest in high-fat and high-sugar foods
In the Stomach
- Slowed gastric emptying: Food moves through your stomach more slowly, keeping you feeling full longer
- Earlier satiety signals: You feel satisfied with smaller portions
In the Pancreas
- Improved insulin release: Stimulates insulin secretion in response to blood sugar (not randomly, reducing hypoglycemia risk)
- Reduced glucagon: Lowers the hormone that raises blood sugar
The Available Medications
Semaglutide Products
| Product | Indication | Delivery | Frequency | Max Dose |
|---|---|---|---|---|
| Ozempic | Type 2 diabetes | Weekly injection | Once weekly | 2.0 mg |
| Wegovy | Weight management | Weekly injection | Once weekly | 2.4 mg |
| Rybelsus | Type 2 diabetes | Daily pill | Once daily | 14 mg |
All three contain semaglutide — the same molecule, different delivery methods and approved uses. Novo Nordisk manufactures all three. For details, see our Ozempic vs Wegovy comparison.
Tirzepatide Products
| Product | Indication | Delivery | Frequency | Max Dose |
|---|---|---|---|---|
| Mounjaro | Type 2 diabetes | Weekly injection | Once weekly | 15 mg |
| Zepbound | Weight management | Weekly injection | Once weekly | 15 mg |
Tirzepatide is a "dual agonist" — it activates both GLP-1 and GIP receptors, potentially providing greater metabolic effects. Eli Lilly manufactures both. For details, see our Mounjaro vs Zepbound comparison.
Older GLP-1 Medications
- Saxenda (liraglutide): Daily injection, FDA-approved for weight management. Less effective than semaglutide/tirzepatide but still meaningful.
- Trulicity (dulaglutide): Weekly injection for type 2 diabetes. Less commonly prescribed for weight management.
What Results Can You Expect?
Weight Loss
Average weight loss from clinical trials:
| Medication | Average Weight Loss | Timeline |
|---|---|---|
| Wegovy (semaglutide 2.4mg) | ~15% of body weight | 68 weeks |
| Zepbound (tirzepatide 15mg) | ~21% of body weight | 72 weeks |
| Ozempic (semaglutide 1mg) | ~5-7% of body weight | 30 weeks |
| Saxenda (liraglutide 3mg) | ~8% of body weight | 56 weeks |
Important: These are averages. Individual results vary significantly. Some patients lose more, some less. About 10-15% of patients are "non-responders" who don't achieve meaningful weight loss.
Blood Sugar Control
For patients with type 2 diabetes, GLP-1 medications typically reduce HbA1c by 1.0-2.3%, often bringing blood sugar into target range when other medications haven't.
Timeline of Changes
| Time | What You'll Notice |
|---|---|
| Week 1-2 | Reduced appetite, may feel slightly nauseated |
| Week 3-6 | Appetite suppression strengthens, "food noise" decreases |
| Month 2-3 | Noticeable weight loss (clothes fitting differently) |
| Month 3-6 | Significant weight change, energy often improves |
| Month 6-12 | Approaching maximum weight loss, side effects typically stabilized |
| Year 1+ | Weight maintenance phase (continued medication usually needed) |
Side Effects: What to Expect
Most side effects are gastrointestinal and improve over time:
- Nausea (most common) — usually worst during dose increases, improves within 2-4 weeks
- Constipation or diarrhea — slowed digestion affects bowel habits
- Decreased appetite — this is the intended effect, but can feel extreme initially
- Fatigue — often related to reduced caloric intake, not the medication itself
Serious side effects are rare but include pancreatitis, gallbladder problems, and allergic reactions. For a complete guide, see our GLP-1 side effects guide.
How to Get Started
1. Check Your Eligibility
- BMI ≥ 30 for weight management, or BMI ≥ 27 with a weight-related condition
- Type 2 diabetes for diabetes indications
2. Talk to Your Doctor
- Schedule an appointment specifically to discuss GLP-1 medications
- Bring your weight history and relevant health records
- See our how to get prescribed guide for detailed preparation tips
3. Navigate Insurance
- Most plans require prior authorization
- Coverage for weight management varies — prepare for potential appeals
- See our insurance coverage guide
4. Start Treatment
- Follow the gradual dose titration schedule
- See our semaglutide dosing guide or tirzepatide dosing guide
5. Support Your Treatment
- Prioritize protein (60-80g daily) to preserve muscle mass
- Stay hydrated (at least 2 liters daily)
- Exercise regularly — especially resistance training
- Track your progress (weight, measurements, energy levels)
Common Myths and Misconceptions
"It's the easy way out"
GLP-1 medications address biological mechanisms that make weight loss difficult. They correct hormonal imbalances, not willpower deficits. Patients still need to make dietary changes and exercise to maximize results.
"You'll gain it all back when you stop"
Weight regain after stopping is real — studies show approximately two-thirds of lost weight may return within a year. This is why GLP-1 therapy is often considered long-term treatment for a chronic condition, similar to blood pressure medication.
"They're just for vanity"
Obesity is associated with over 200 health conditions. Weight loss of 5-10% significantly reduces risk of type 2 diabetes, cardiovascular disease, sleep apnea, and joint problems. These medications treat a medical condition with serious health consequences.
"They're dangerous"
Like all medications, GLP-1 agonists have side effects. But their safety profile is well-established through large clinical trials (thousands of participants, years of follow-up). The health risks of untreated obesity are typically greater than the risks of medication.
Frequently Asked Questions
How quickly will I lose weight?
Most patients notice reduced appetite within 1-2 weeks. Visible weight loss typically begins within 4-8 weeks. Maximum weight loss usually occurs at 6-12 months of treatment.
Do I have to inject myself?
For most GLP-1 medications, yes — it's a weekly subcutaneous injection using a pre-filled pen device (like an EpiPen). The needle is very small and most patients report minimal discomfort. Oral semaglutide (Rybelsus) is available as a daily pill but is currently only approved for diabetes, not weight management.
How long do I need to take GLP-1 medication?
Current evidence suggests ongoing treatment is needed to maintain weight loss. Think of it like blood pressure medication — it works while you take it. Your doctor will help you develop a long-term plan based on your individual response and goals.
Can anyone take GLP-1 medications?
No. They're not suitable for people with certain thyroid conditions, history of pancreatitis, pregnancy, or type 1 diabetes. A healthcare provider must evaluate your eligibility.
Will my insurance cover it?
Coverage varies widely. Most plans cover GLP-1 medications for type 2 diabetes. Coverage for weight management is growing but inconsistent. See our insurance guide for strategies.
What happens during the first week?
You'll take a low starting dose. Most people feel mild nausea and reduced appetite. Some feel almost nothing at this dose — that's normal. The starting dose is just for your body to adjust.
Medically Reviewed
Dr. James Mitchell, MD, DABOM·